Drugs / AMITIFADINE
AMITIFADINE
also known as
DOV 21, 947 · Amitifadina · AMITIFADINE HYDROCHLORIDE · DOV-21,947 HYDROCHLORIDE · EB-1010 · EB-1010 HYDROCHLORIDE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT01318434 | Feb 2011 → Feb 2013 | major depressive disorder | Euthymics BioScience, Inc. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00659347 Comparator | Mar → Dec 2008 | major depressive disorder | DOV Pharmaceutical, Inc. | Terminated | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMITIFADINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL592374 ↗ |
| Known as | Amitifadina | ChEMBL registry synonym — accepted as the source's own label CHEMBL592374 ↗ |
| Known as | AMITIFADINE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL592374 ↗ |
| Known as | DOV 21, 947 | “DOV 21,947 is an investigational drug that is being developed for the treatment of depression.” NCT00659347 ↗1“Drug: DOV 21, 947” NCT00659347 ↗ |
| Known as | DOV-21,947 HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL592374 ↗ |
| Known as | EB-1010 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01318434 ↗ |
| Known as | EB-1010 HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL592374 ↗ |
| Modality | Small molecule | — CHEMBL592374 ↗ |
| Route | Oral | “two oral dose levels.” NCT00659347 ↗ |